{"organizations": [], "uuid": "9e580369ee9f8c840565cfec48797662cbabc34d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180425.html", "section_title": "Archive News &amp; Video for Wednesday, 25 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-dar-bioscience-enters-into-exclusi/brief-dar-bioscience-enters-into-exclusive-worldwide-license-agreement-for-juniper-pharmaceuticals-intravaginal-ring-technology-platform-idUSFWN1S20RR", "country": "US", "domain_rank": 408, "title": "BRIEF-Daré Bioscience Enters Into Exclusive Worldwide License Agreement For Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-25T20:10:00.000+03:00", "replies_count": 0, "uuid": "9e580369ee9f8c840565cfec48797662cbabc34d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-dar-bioscience-enters-into-exclusi/brief-dar-bioscience-enters-into-exclusive-worldwide-license-agreement-for-juniper-pharmaceuticals-intravaginal-ring-technology-platform-idUSFWN1S20RR", "ord_in_thread": 0, "title": "BRIEF-Daré Bioscience Enters Into Exclusive Worldwide License Agreement For Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "ivr", "sentiment": "negative"}, {"name": "dare bioscience inc", "sentiment": "negative"}, {"name": "juniper pharmaceuticals", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 25 (Reuters) - Dare Bioscience Inc:\n* DARÉ BIOSCIENCE, INC. ENTERS INTO EXCLUSIVE WORLDWIDE LICENSE AGREEMENT FOR JUNIPER PHARMACEUTICALS’ INTRAVAGINAL RING (IVR) TECHNOLOGY PLATFORM\n* DARE BIOSCIENCE INC - SECURED EXCLUSIVE LICENSE TO JUNIPER PHARMACEUTICALS’ INTRAVAGINAL RING TECHNOLOGY, INCLUDING JUNIPER’S 3 PRECLINICAL CANDIDATES Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-25T20:10:00.000+03:00", "crawled": "2018-04-26T20:53:37.010+03:00", "highlightTitle": ""}